Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
H01AC06
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
||
|
NCI_THESAURUS |
C76358
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
||
|
NDF-RT |
N0000182144
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
||
|
WHO-VATC |
QH01AC06
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
||
|
WIKIPEDIA |
Designer-drugs-Tesamorelin
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID00583207
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
PRIMARY | |||
|
CHEMBL1237026
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
PRIMARY | |||
|
m10590
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
PRIMARY | Merck Index | ||
|
4170
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
PRIMARY | |||
|
6959
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
PRIMARY | |||
|
63626
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
PRIMARY | |||
|
SUB32399
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
PRIMARY | |||
|
C479538
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
PRIMARY | |||
|
91886675
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
PRIMARY | |||
|
DB08869
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
PRIMARY | |||
|
C77425
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
PRIMARY | |||
|
SS-04
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
PRIMARY | |||
|
1044584
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
PRIMARY | RxNorm | ||
|
MQG94M5EEO
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
PRIMARY | |||
|
8786
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
PRIMARY | |||
|
MQG94M5EEO
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
PRIMARY | |||
|
N0000009327
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
PRIMARY | Increased GHRH Activity [PE] | ||
|
218949-48-5
Created by
admin on Fri Dec 15 17:23:05 UTC 2023 , Edited by admin on Fri Dec 15 17:23:05 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)